Related Experiment Videos
Studies on the structure and function of the apolipoprotein(a) gene
1Division of Cardiovascular Medicine, Stanford University School of Medicine, CA 94305-5246.
Clinical Genetics
|July 1, 1994
Summary
Lipoprotein(a) (Lp(a)) is a key inherited risk factor for atherosclerosis. Research into its gene structure and expression in transgenic mice reveals its role in arterial lesion development.
Area of Science:
- Biochemistry
- Genetics
- Cardiovascular Science
Background:
- Lipoprotein(a) (Lp(a)) is an LDL-like particle and a significant inherited risk factor for atherosclerosis.
- Lp(a) differs from LDL by the presence of apolipoprotein(a).
- The apolipoprotein(a) gene structure is homologous to plasminogen, suggesting potential interference with plasminogen activity in Lp(a) pathophysiology.
Purpose of the Study:
- To investigate the genetic basis and expression of apolipoprotein(a).
- To understand the role of Lp(a) in the development of atherosclerosis.
Main Methods:
- Identification and characterization of apolipoprotein(a) gene family members.
- Analysis of gene proximity using overlapping genomic clones.
- Investigation of apolipoprotein(a) gene expression regulation.
- Generation of transgenic mice with the human apolipoprotein(a) gene.
Main Results:
- Six highly related apolipoprotein(a) genes were identified, with four located closely together.
- Transgenic mice expressing the human apolipoprotein(a) gene developed arterial lesions.
Conclusions:
- The genetic and molecular basis of Lp(a) provides insights into its role as an atherosclerosis risk factor.
- Transgenic mouse models demonstrate the causal link between apolipoprotein(a) and arterial lesion formation.